Trade OCUL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Ocular Therapeutix, Inc. (OCUL) is trading at US$9.99, down 1.48% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$2.43B. Over the past 52 weeks, OCUL has traded between US$6.23 and US$16.44. On Syfe you can trade OCUL with $0 commission and add it to your watchlist.
| Previous close | US$10.14 |
|---|---|
| Market cap | US$2.43B |
| 52-week range | US$6.23 – US$16.44 |
| Volume | 4.1M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Year: 2014
Ocular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says
Aug 4, 3:59 PM · MT Newswires
Ocular Therapeutix's Q2 Net Loss Widens, Revenue Flat
Aug 3, 11:16 AM · MT Newswires
--Earnings Flash (OCUL) Ocular Therapeutix Posts Q2 Net Loss $0.35 a Share, vs. FactSet Est of $0.40 Loss
Aug 3, 11:11 AM · MT Newswires
Ocular Therapeutix, Inc. (OCUL) stock is trading at US$9.99, -1.48% from the previous close of US$10.14.
The market cap for Ocular Therapeutix, Inc. (OCUL) stock is approximately US$2.43B.
The 52-week high for Ocular Therapeutix, Inc. (OCUL) stock is US$16.44.
The 52-week low for Ocular Therapeutix, Inc. (OCUL) stock is US$6.23.
Ocular Therapeutix, Inc. (OCUL) does not currently pay a dividend.
Stay on top of OCUL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
